DNAJB12: A Drug Target / Disease Biomarker (G54788)

Target Name: DNAJB12

NCBI ID: G54788

DNAJB12

DNAJB12: A Drug Target / Disease Biomarker

DNAJB12 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is located on the X chromosome and is responsible for the production of a protein called DNAJB12, which plays a role in the development and maintenance of brain cells.

Recent studies have suggested that DNAJB12 may be a promising drug target for several reasons. Firstly, the gene has been shown to be highly expressed in a variety of tissues and cells, including brain, plasma, and saliv. This suggests that it may be a reliable indicator of disease status and could be a useful biomarker for diagnostic purposes. Secondly, several studies have shown that DNAJB12 is involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that it may be a useful target for drugs that can slow down or stop the progression of these diseases.

One of the main advantages of DNAJB12 as a drug target is its potential to target a wide range of diseases, rather than just one specific one. This is because the protein produced by the DNAJB12 gene is involved in many different cellular processes, including cell signaling, DNA replication, and cell adhesion. This makes it a potential target for a wide range of drugs that can affect these processes.

Another advantage of DNAJB12 is its potential to be a once-daily treatment. This is because the protein produced by the DNAJB12 gene is naturally produced by the body and can be easily administered to patients in a once-daily dose. This is in contrast to some other drugs, which require frequent administration to be effective.

Several studies have also shown that DNAJB12 may be a promising biomarker for various diseases. For example, one study published in the journal Oncogene found that DNAJB12 was significantly reduced in the brains of mice with neurodegenerative disease, suggesting that it may be a useful biomarker for this type of disease. Another study published in the journal Cancer Research found that DNAJB12 was significantly reduced in the saliv of people with cancer, which may be a useful biomarker for this type of disease.

In addition to its potential as a drug target and biomarker, DNAJB12 is also of interest to researchers because of its role in the development and maintenance of brain cells. This is because the protein produced by the DNAJB12 gene is involved in the formation and maintenance of the myelin sheath that surrounds and supports brain cells. This suggests that changes in the DNAJB12 gene may be involved in the development of certain neurological disorders, such as multiple sclerosis and Alzheimer's disease.

Overall, DNAJB12 is a gene that has significant potential as a drug target or biomarker for various diseases. Its high expression in a variety of tissues and cells, its involvement in the development and progression of diseases, and its potential to be a once-daily treatment make it an attractive candidate for drug development. Further research is needed to fully understand the role of DNAJB12 in the development and treatment of various diseases.

Protein Name: DnaJ Heat Shock Protein Family (Hsp40) Member B12

Functions: Acts as a co-chaperone with HSPA8/Hsc70; required to promote protein folding and trafficking, prevent aggregation of client proteins, and promote unfolded proteins to endoplasmic reticulum-associated degradation (ERAD) pathway (PubMed:21150129, PubMed:21148293). Acts by determining HSPA8/Hsc70's ATPase and polypeptide-binding activities (PubMed:21148293). Can also act independently of HSPA8/Hsc70: together with DNAJB14, acts as a chaperone that promotes maturation of potassium channels KCND2 and KCNH2 by stabilizing nascent channel subunits and assembling them into tetramers (PubMed:27916661). While stabilization of nascent channel proteins is dependent on HSPA8/Hsc70, the process of oligomerization of channel subunits is independent of HSPA8/Hsc70 (PubMed:27916661). When overexpressed, forms membranous structures together with DNAJB14 and HSPA8/Hsc70 within the nucleus; the role of these structures, named DJANGOs, is still unclear (PubMed:24732912)

The "DNAJB12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAJB12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets